Sven Bulterijs is our PhD student at the University of Ghent, working in the C. elegans lab and under supervision of Prof. Braeckman. His position is sponsored via a VLAIO Baekeland mandate. His focus and scientific interest is in biogerontology. He has written multiple reviews such as “Metformin as geroprotector” and more recently “Phenotypic Screening in C. elegans as a Tool for the Discovery of New Geroprotective Drug”. Sven has spoken at multiple international conferences on geroprotectors and aging research. He has an interesting parallel career in the aging field since he established the non-profit organization Heales. Heales organizes the Eurosymposium on Healthy Ageing, creating an interesting longevity networking opportunity. Further, he is director at LongeCity and worked in the prof. Spiegel laboratory at Yale University on the synthesis of glucosepane. Sven holds a master’s degree in Biochemistry and Biotechnology from the University of Ghent, Belgium.